Personal information

No personal information available

Activities

Collapse all

Employment (1)

Instituto de Investigación Sanitaria La Fe: Valencia, ES

Research collaborator (Grupo de Investigación del Cáncer)
Employment
Source: Self-asserted source
Gaspar Reynés

Education and qualifications (1)

Universitat de Valencia: Valencia, ES

MD., PhD.
Education
Source: Self-asserted source
Gaspar Reynés

Professional activities (2)

Grupo Español de Oncología Genitourinaria (SOGUG): Madrid, ES

Membership
Source: Self-asserted source
Gaspar Reynés

Grupo Español de Investigación en Neurooncología: Madrid, ES

Membership
Source: Self-asserted source
Gaspar Reynés

Funding (2)

Estudio del secretoma en subtipos inmunohistológicos de glioblastoma y en grupos de larga y corta supervivencia

Grant
Grupo Español de Investigación en Neurooncología (GEINO) (Madrid, ES)
Source: Self-asserted source
Gaspar Reynés

Tumor and circulating biomarkers in advanced renal cell carcinoma treated with sunitinib

Grant
Pfizer Inc (New York, US)
Source: Self-asserted source
Gaspar Reynés

Works (44)

Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study

Cancer Chemotherapy and Pharmacology
2019-10-31 | Journal article
DOI: 10.1007/s00280-019-03913-3
Contributors: Javier Munárriz; Gaspar Reynés; Luisa Sánchez-Lorenzo; Emilio Esteban; Laura Basterretxea; Leticia de Avila-Lizárraga; Miguel Angel Climent; María José Juan-Fita; Corina Escoín; Javier Puente et al.
Source: check_circle
Crossref

Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2018-05 | Journal article
DOI: 10.1007/s12094-018-1883-7
PMID: 29737461
Contributors: Balaña C; Estival A; Teruel I; Hardy-Werbin M; Sepulveda J; Pineda E; Martinez-García M; Gallego O; Luque R; Gil-Gil M et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Correction to: SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2018-01 | Journal article
DOI: 10.1007/s12094-017-1814-z
PMID: 29209952
Contributors: Sepúlveda-Sánchez JM; Muñoz Langa J; Arráez MÁ; Fuster J; Hernández Laín A; Reynés G; Rodríguez González V; Vicente E; Vidal Denis M; Gallego Ó
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Radium-223 international early access program: results from the Spanish subset.

Future oncology (London, England)
2017-12 | Journal article
DOI: 10.2217/fon-2017-0297
PMID: 29232987
Contributors: Carles J; Méndez MJ; Pinto Á; Sáez MI; Arranz JA; Maroto P; López-Criado P; Mellado B; Donas JG; Hernando S et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2017-11 | Journal article
DOI: 10.1007/s12094-017-1790-3
PMID: 29124520
PMC: PMC5785601
Contributors: Sepúlveda-Sánchez JM; Muñoz Langa J; Arráez MÁ; Fuster J; Hernández Laín A; Reynés G; Rodríguez González V; Vicente E; Vidal Denis M; Gallego Ó
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.

Neuro-oncology
2017-10 | Journal article
DOI: 10.1093/neuonc/nox105
PMID: 28575464
PMC: PMC5737732
Contributors: Sepúlveda-Sánchez JM; Vaz MÁ; Balañá C; Gil-Gil M; Reynés G; Gallego Ó; Martínez-García M; Vicente E; Quindós M; Luque R et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Erratum: Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study.

Oncology letters
2017-07 | Journal article
DOI: 10.3892/ol.2017.6689
PMID: 28989538
PMC: PMC5620482
Contributors: Sepúlveda-Sánchez JM; Conde-Moreno A; Barón M; Pardo J; Reynés G; Belenguer A
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study.

Oncology letters
2017-04 | Journal article
DOI: 10.3892/ol.2017.5988
PMID: 28599411
PMC: PMC5452997
Contributors: Sepúlveda-Sánchez JM; Conde-Moreno A; Barón M; Pardo J; Reynés G; Belenguer A
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib.

Scientific reports
2017-01 | Journal article
DOI: 10.1038/srep41371
PMID: 28117391
PMC: PMC5259767
Contributors: Cebrián A; Gómez Del Pulgar T; Méndez-Vidal MJ; Gonzálvez ML; Lainez N; Castellano D; García-Carbonero I; Esteban E; Sáez MI; Villatoro R et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.

PloS one
2016-08 | Journal article
DOI: 10.1371/journal.pone.0161484
PMID: 27557121
PMC: PMC4996463
Contributors: Molina D; Pérez-Beteta J; Martínez-González A; Sepúlveda JM; Peralta S; Gil-Gil MJ; Reynes G; Herrero A; De Las Peñas R; Luque R et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.

Journal of neuro-oncology
2016-02 | Journal article
DOI: 10.1007/s11060-016-2065-5
PMID: 26847813
Contributors: Balana C; De Las Penas R; Sepúlveda JM; Gil-Gil MJ; Luque R; Gallego O; Carrato C; Sanz C; Reynes G; Herrero A et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma.

Anti-cancer drugs
2016-02 | Journal article
DOI: 10.1097/cad.0000000000000314
PMID: 26574999
Contributors: Reynés G; Martínez-Sales V; Vila V; Balañá C; Pérez-Segura P; Vaz MA; Benavides M; Gallego O; Palomero I; Gil-Gil M et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

ATCT-05OBJECTIVE RESPONSE (OR) TO NEOADJUVANT TREATMENT IN GLIOBLASTOMA AND ITS IMPACT ON OVERALL SURVIVAL (OS). A META-ANALYSIS OF NEOADJUVANT TRIALS OF THE SPANISH GROUP FOR RESEARCH IN NEUROONCOLOGY (GEINO).

Neuro-oncology
2015-11 | Journal article
DOI: 10.1093/neuonc/nov206.05
PMC: PMC4638556
Contributors: Balana C; Gil Gil M; Gallego O; Berrocal A; Sepulveda J; Penas Rdl; Herrero A; Reynes G; Luque R
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2015-06 | Journal article
DOI: 10.1007/s12094-015-1304-0
PMID: 26033428
Contributors: Sepúlveda JM; Belda-Iniesta C; Gil-Gil M; Pérez-Segura P; Berrocal A; Reynés G; Gallego O; Capellades J; Ordoñez JM; La Orden B et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

P17.04RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP.

Neuro-oncology
2014-09 | Journal article
DOI: 10.1093/neuonc/nou174.334
PMC: PMC4185699
Contributors: Balaña C; Peñas Rdl; Sepúlveda J; Gil MG; Luque R; Gallego O; Reynes G; Herrero A; Perez-Segura P; Berrocal A
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

P18.08A MULTICENTRIC, OBSERVATIONAL, NON INTERVENTIONAL STUDY OF EFFICACY AND SAFETY OF LACOSAMIDE FOR THE TREATMENT OF EPILEPTIC SEIZURES IN PATIENTS WITH BRAIN TUMORS.

Neuro-oncology
2014-09 | Journal article
DOI: 10.1093/neuonc/nou174.432
PMC: PMC4185808
Contributors: Pardo-Moreno J; Sepúlveda J; Conde-Moreno A; Barón M; Reynes G; Belenguer A
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

A phase I study of irinotecan in combination with metronomic temozolomide in patients with recurrent glioblastoma.

Anti-cancer drugs
2014-07 | Journal article
DOI: 10.1097/cad.0000000000000059
PMID: 24322542
Contributors: Reynés G; Balañá C; Gallego O; Iglesias L; Pérez P; García JL
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma.

Cancer chemotherapy and pharmacology
2014-02 | Journal article
DOI: 10.1007/s00280-014-2413-0
PMID: 24531612
Contributors: García Del Muro X; Gallardo E; García Carbonero I; Laínez N; José Méndez M; Maroto P; Ochoa de Olza M; Puente J; Reynes G; Rubio J et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a phase II study.

Targeted oncology
2014-01 | Journal article
DOI: 10.1007/s11523-014-0305-1
PMID: 24424564
Contributors: Balaña C; Gil MJ; Perez P; Reynes G; Gallego O; Ribalta T; Capellades J; Gonzalez S; Verger E
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Alpha emitter radium-223 and survival in metastatic prostate cancer.

The New England journal of medicine
2013-07 | Journal article
DOI: 10.1056/nejmoa1213755
PMID: 23863050
Contributors: Parker C; Nilsson S; Heinrich D; Helle SI; O'Sullivan JM; Fosså SD; Chodacki A; Wiechno P; Logue J; Seke M et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value.

PloS one
2013-07 | Journal article
DOI: 10.1371/journal.pone.0069034
PMID: 23922679
PMC: PMC3726739
Contributors: Reynés G; Vila V; Fleitas T; Reganon E; Font de Mora J; Jordá M; Martínez-Sales V
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study.

British journal of cancer
2013-05 | Journal article
DOI: 10.1038/bjc.2013.270
PMID: 23722472
PMC: PMC3694249
Contributors: de la Piedra C; Alcaraz A; Bellmunt J; Meseguer C; Gómez-Caamano A; Ribal MJ; Vázquez F; Anido U; Samper P; Esteban E et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2013-03 | Journal article
DOI: 10.1007/s12094-013-1020-6
PMID: 23463593
Contributors: Fleitas T; Martínez-Sales V; Vila V; Reganon E; Mesado D; Martín M; Gómez-Codina J; Montalar J; Reynés G
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer.

PloS one
2012-10 | Journal article
DOI: 10.1371/journal.pone.0047365
PMID: 23077602
PMC: PMC3471832
Contributors: Fleitas T; Martínez-Sales V; Vila V; Reganon E; Mesado D; Martín M; Gómez-Codina J; Montalar J; Reynés G
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

CLIN-NEURO/MEDICAL ONCOLOGY.

Neuro-oncology
2012-10 | Journal article
DOI: 10.1093/neuonc/nos229
PMC: PMC3488783
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO).

Anti-cancer drugs
2012-07 | Journal article
DOI: 10.1097/cad.0b013e3283534d3e
PMID: 22634799
Contributors: Gil MJ; de Las Peñas R; Reynés G; Balañá C; Peréz-Segura P; García-Velasco A; Mesia C; Gallego O; Fernández-Chacón C; Martínez-García M et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

SEOM guideline for the treatment of malignant glioma.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2012-07 | Journal article
DOI: 10.1007/s12094-012-0839-6
PMID: 22721801
Contributors: Berrocal A; Gil M; Gallego Ó; Balaña C; Pérez Segura P; García-Mata J; Reynes G; SEOM (Spanish Society of Clinical Oncology)
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

MEDICAL AND NEURO-ONCOLOGY.

Neuro-oncology
2011-11 | Journal article
DOI: 10.1093/neuonc/nor152
PMC: PMC3199176
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Circulating endothelial and endothelial progenitor cells in non-small-cell lung cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2010-08 | Journal article
DOI: 10.1007/s12094-010-0549-x
PMID: 20709649
Contributors: Fleitas T; Martínez-Sales V; Gómez-Codina J; Martín M; Reynés G
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma.

Journal of neuro-oncology
2010-07 | Journal article
DOI: 10.1007/s11060-010-0290-x
PMID: 20607353
Contributors: Reynés G; Vila V; Martín M; Parada A; Fleitas T; Reganon E; Martínez-Sales V
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experience.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2009-12 | Journal article
DOI: 10.1007/s12094-009-0452-5
PMID: 20045790
Contributors: Díaz R; Reynes G; Tormo A; de Juan M; Gironés R; Segura A; Aparicio J; Richart P; de la Cueva H; García J
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2009-12 | Journal article
DOI: 10.1016/j.jocn.2009.02.035
PMID: 19959364
Contributors: Prat R; Galeano I; Lucas A; Martínez JC; Martín M; Amador R; Reynés G
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Extended-schedule dose-dense temozolomide in refractory gliomas.

Journal of neuro-oncology
2009-08 | Journal article
DOI: 10.1007/s11060-009-9980-7
PMID: 19669096
PMC: PMC2808507
Contributors: Berrocal A; Perez Segura P; Gil M; Balaña C; Garcia Lopez J; Yaya R; Rodríguez J; Reynes G; Gallego O; Iglesias L et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

[Metastasis of esophageal carcinoma resembling hematoma of lateral pontine tegmentum].

Medicina clinica
2005-09 | Journal article
DOI: 10.1157/13078426
PMID: 16159559
Contributors: Magraner MJ; Alfaro A; Vera F; Reynes G
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Neoadjuvant cisplatin and etoposide, with or without tamoxifen, prior to radiotherapy in high-grade gliomas: a single-center experience.

Anti-cancer drugs
2005-03 | Journal article
DOI: 10.1097/00001813-200503000-00012
PMID: 15711185
Contributors: Díaz R; Jordá MV; Reynés G; Aparicio J; Segura A; Amador R; Calderero V; Beltrán A
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas.

Clinical cancer research : an official journal of the American Association for Cancer Research
2004-08 | Journal article
DOI: 10.1158/1078-0432.ccr-04-0392
PMID: 15297393
Contributors: Paz MF; Yaya-Tur R; Rojas-Marcos I; Reynes G; Pollan M; Aguirre-Cruz L; García-Lopez JL; Piquer J; Safont MJ; Balaña C et al.
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Toxic epidermal necrolysis associated with interleukin-2.

The Annals of pharmacotherapy
2002-07 | Journal article
DOI: 10.1345/aph.1a200
PMID: 12086549
Contributors: Segura Huerta AA; Tordera P; Cercós AC; Yuste AL; López-Tendero P; Reynés G
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Primitive neuroectodermal kidney tumor.

Medical and pediatric oncology
2002-02 | Journal article
DOI: 10.1002/mpo.1296
PMID: 11813190
Contributors: Segura A; Pérez J; Reynés G; Yuste A; Vera F; Petschen I
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

[Recommendations on the multidisciplinary management in patients with malignant glioma]

Medicina clinica
2001-02 | Journal article
DOI: 10.1016/s0025-7753(01)71793-9
PMID: 11333738
Contributors: Graus F; Cerdá M; Piquer J; Reynés G; Santos M
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients.

Annals of oncology : official journal of the European Society for Medical Oncology
1997-06 | Journal article
DOI: 10.1023/a:1008212826956
PMID: 9261523
Contributors: Maestu I; Pastor M; Gómez-Codina J; Aparicio J; Oltra A; Herranz C; Montalar J; Munárriz B; Reynés G
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

Extragonadal germ cell tumors: prognostic factors and long-term follow-up.

European urology
1995-01 | Journal article
PMID: 8521889
Contributors: Aparicio J; Montalar J; Munárriz EB; Reynés G; Gómez-Codina J; Pastor M; Herranz C
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

[Burkitt's lymphoma in relation to acquired immunodeficiency syndrome (AIDS)]

Revista clinica espanola
1986-11 | Journal article
PMID: 3562958
Contributors: Massuti B; López Aldeguer J; Munarriz EB; Gómez Gandía S; Reynés G; Montalar J
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

[Extragonadal germinal tumor syndrome]

Revista clinica espanola
1986-03 | Journal article
PMID: 3012668
Contributors: Massuti B; González Pont G; López Aldeguer J; Hernández M; del Moral F; Reynés G; Montalar J
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central

[Infections due to herpes-varicella viruses in Hodgkin's disease (author's transl)]

Medicina clinica
1981-05 | Journal article
PMID: 6264237
Contributors: Redón J; Herranz C; Montalar J; Navarro JR; Blanes A; Munarriz B; Reynés G; Caballero M
Source: Self-asserted source
Gaspar Reynés via Europe PubMed Central
How many people are using ORCID?